The History of Injective (INJ) Crypto Asset

Injective Protocol (INJ) was founded in 2017 by Eric Chen and Albert Chon, setting out with the aim to transform decentralized financial markets by using blockchain technology. The project started as part of Innovating Capital, a venture capital and private equity firm which provided early funding and support. In its foundational period, Injective concentrated on building a decentralized exchange (DEX) that would enable permissionless trading, negate front-running, and allow for cross-chain derivatives. These goals placed Injective as a distinctive player in the decentralized finance (DeFi) sector.

Since its inception, Injective has utilized the Cosmos SDK-based blockchain framework, leveraging Tendermint as its consensus mechanism. The decision to base the project in the Cosmos ecosystem allowed Injective to maximize interoperability with other blockchains, fostering the use of its native INJ token across different networks. This move was crucial as it set Injective apart from many other DEXs operating only within limited ecosystems.

In the early development stages, the project garnered attention and received strategic investments. Vitalik Buterin, the co-founder of Ethereum, is reported to have supported its development, and various notable venture funds such as Binance Labs participated in the funding rounds, giving the protocol much-needed visibility in the wider crypto community.

A significant milestone in the asset's history was the launch of the Injective testnet. The testnet phase proved an essential step as it enabled the team to fine-tune the system's functionalities and gather feedback from users. Following the testnet period, Injective officially launched its mainnet. This release allowed traders to fully utilize the platform’s decentralized exchange and derivatives platform.

Its decentralized exchange supports a variety of assets and boasts a highly scalable infrastructure without compromising speed or security. Throughout this period, Injective facilitated a key innovation—the introduction of decentralized spot and derivatives trading across multiple blockchains. This innovation enabled investors to engage in unrestricted trading of a variety of crypto assets beyond just the Ethereum network.

A sizable portion of the development milestones by Injective has been based on community governance, meaning that token holders can vote on future upgrades of the protocol. The INJ token's utility includes its purpose in governance decisions, staking within the network for block validation, and economic alignment for traders and protocol participants alike.